Distribution of serum creatine kinase activity in young healthy persons

Clinica Chimica Acta

Volumn 279, Issue 1-2, 1999, Pages 107-115

  Lev, Eli I ^a,b   Tur Kaspa, Ilan ^a,b   Ashkenazy, Isaac ^a,b   Reiner, Anat ^a   Faraggi, David ^c   Shemer, Joshua ^a,b   Argov, Zohar ^d  

^a Medical Corps   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d HEBREW UNIVERSITY   (Israel)

Author keywords

Alcohol; BMI; Creatine kinase; Myoglobin; Physical activity

Indexed keywords

CREATINE KINASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HABIT; HUMAN; MALE; METHODOLOGY; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REFERENCE VALUE; SEX DIFFERENCE; SMOKING;

ADULT; BODY MASS INDEX; CREATINE KINASE; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MYOGLOBIN; NORMAL DISTRIBUTION; RANDOM ALLOCATION; REFERENCE VALUES;

EID: 0032932693     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00180-6     Document Type: Article

References (31)

1. Nevins M.A., Saran M., Bright M., Lyon L.J. Pitfalls in interpreting serum creatine phosphokinase activity. JAMA. 224:1973;1382-1387.
2. Nicholson G.A., Mcleod J.G., Morgan G.et al. Variable distributions of serum creatine kinase reference values. Relationship to exercise activity. J Neurol Sci. 71:1985;233-245.
3. Sobel S.E., Shell W.E. Serum enzyme determinations in the diagnosis and assessment of myocardial infarction. Circulation. 45:1972;471-482.
4. Hanisch-Kuckhoff E., Jerusalem F., Mietz F. Asymptomatic hyper-CK-emia (HCK): Incidental finding or subclinical myopathy. J Neurol Sci. 98(Suppl):1990;219.
5. Sunohara N., Takagi A., Nonaka I., Sugita H., Satoyoshi E. Idiopathic hyperCKemia. Neurology. 34:1984;544-547.
6. Brewster L.M., de-Visser M. Persistent hyperCkemia: Fourteen patients studied in retrospect. Acta Neurol Scand. 77:1988;60-63.
7. Wong E.T., Cobb C., Umehara M.K.et al. Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol. 79:1983;582-586.
8. Black H.R., Quallich H., Gareleck C.B. Racial differences in creatine kinase levels. Am J Med. 81:1986;479-487.
9. Meltzer H.Y., Holy P.A. Black-white differences in serum creatine phosphokinase (CPK) activity. Clin Chim Acta. 54:1974;215-224.
10. Worrall B.Y.G., Phongsathorn V., Hooper R.J.L., Paice E.W. Racial variation in serum creatine kinase unrelated to lean body mass. Br J Rheum. 29:1990;371-373.
11. Sherwood R.A., Lambert A., Newham D.J., Wassif W.S., Peters T.J. The effect of eccentric exercise on serum creatine kinase activity in different ethnic groups. Ann Clin Biochem. 33:1996;324-329.
12. Miller W.G., Chinchill V.M., Gruemer H.D., Nance W.E. Sampling from a skewed population distribution as exemplified by estimation of the creatine kinase upper reference limit. Clin Chem. 30:1984;18-23.
13. Harris E.K., Wong E.T., Shaw S.T. Statistical criteria for separate reference intervals: Race and gender groups in creatine kinase. Clin Chem. 37:1991;1580-1582.
14. Henderson A.R., McQueen M.J., Patten R.L., Krishnan S., Wood D.E., Webb S. Testing for creatine kinase and creatine kinase-2 in Ontario: Reference ranges and assay types. Clin Chem. 38:1992;1365-1370.
15. Kairisto V., Hanninen K.P., Leino A.et al. Generation of reference values for cardiac enzymes from hospital admission laboratory data. Eur J Clin Chem Clin Biochem. 32:1994;789-796.
16. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New-York: Chapman and Hall, 1993.
17. Lev E.I., Hendler I., Siebner R., Tashma Z., Wiener M., Tur-Kaspa I. Creatine kinase activity decrease with short-term freezing. Enzyme Protein. 48:1995;238-242.
18. Rosalki S.B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 69:1966;696-705.
19. Szasz G., Gruber W., Bernt E. Creatine kinase in serum. 1. Determination of optimum conditions. Clin Chem. 22:1976;650-656.
20. Griffiths P.D. Serum levels of ATP: Creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta. 13:1966;413-420.
21. Leppanen E.A. Experimental basis of standardized specimen collection: The effect of short moderate exercise on serum K, Na, ASAT, ALAT, CK and LD. Scand J Clin Lab Invest. 49:1989;287-292.
22. Epstein Y. Clinical significance of serum creatine phosphokinase activity levels following exercise. Isr J Med Sci. 31:1995;698-699.
23. Schneider C.M., Dennehy C.A., Rodearmel S.J., Hayward J.R. Effects of physical activity on creatine phosphokinase and the isoenzyme creatine kinase-MB. Ann Emerg Med. 25:1995;520-524.
24. Newham D.J., Jones D.A., Clarkson P.M. Repeated high force eccentric exercise: Effects on muscle pain and damage. J Appl Physiol. 63:1987;1381-1386.
25. Salvadori A., Fanari P., Ruga S., Brunani A., Longhini E. Creatine kinase and creatine kinase-MB isoenzyme during and after exercise testing in normal and obese young people. Chest. 102:1992;1687-1689.
26. Paterson Y., Lawrence E.F. Factors affecting serum creatine phosphokinase levels in normal adult females. Clin Chim Acta. 42:1972;131-139.
27. Driessen-Kletter M.F., Amelink G.J., Barr P.R., van-Gijn J. Myoglobin is a sensitive marker of increased muscle membrane vulnerability. J Neurol. 237:1990;234-238.
28. Kawai H., Sebe T., Nishino H., Nishida Y., Saito S. Light and electron microscopic studies on localization of myoglobin in skeletal muscle cells in neuromuscular diseases. Muscle and Nerve. 14:1991;342-347.
29. Gospe S.M., El Schahawi M., Shanske S.et al. Asymptomatic patient with myophosphorylase deficiency, high CK and the L396P mutation. Neurology. 48(Suppl 3):1997;A320.
30. Weglinski M.R., Wedel D.J., Engel A.G. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg. 84:1997;1038-1041.
31. Klepppe B., Reimers C.D., Altmann C., Pongratz D.E. Findings in 100 patients with idiopathic increase in serum creatine kinase activity. Med Klin. 90:1995;623-627.